Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene

被引：0
|
作者：
Tina Trdan Lušin
Bruno Stieger
Janja Marc
Aleš Mrhar
Jurij Trontelj
Andrej Zavratnik
Barbara Ostanek
机构：
[1] University of Ljubljana,Department of Biopharmacy and Pharmacokinetics, Faculty of Pharmacy
[2] University Hospital Zürich,Department of Clinical Pharmacology and Toxicology
[3] University of Ljubljana,Department of Clinical Biochemistry, Faculty of Pharmacy
[4] University Medical Centre,Department of Endocrinology and Diabetology
来源：
Journal of Translational Medicine | / 10卷
关键词：
Raloxifene; Raloxifene diglucuronide; SLCO1B1; SLCO1B3; Osteoporosis; LC/MS/MS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel
    Iusuf, Dilek
    Hendrikx, Jeroen J. M. A.
    van Esch, Anita
    de Steeg, Evita van
    Wagenaar, Els
    Rosing, Hilde
    Beijnen, Jos H.
    Schinkel, Alfred H.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (01) : 225 - 233
  • [42] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
  • [43] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Anne T Nies
    Mikko Niemi
    Oliver Burk
    Stefan Winter
    Ulrich M Zanger
    Bruno Stieger
    Matthias Schwab
    Elke Schaeffeler
    Genome Medicine, 5
  • [44] Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3
    Gui, Chunshan
    Miao, Yi
    Thompson, Lucas
    Wahlgren, Bret
    Mock, Melissa
    Stieger, Bruno
    Hagenbuch, Bruno
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 584 (01) : 57 - 65
  • [45] Specific and general inhibitors of the three hepatic organic anion transporters OATP1B1 (SLCO1B1), OATP1B3 (SLCO1B3) and OATP2B1 (SLCO2B1)
    Karlgren, Maria
    Ahlin, Gustav
    Vildhede, Anna
    Artursson, Per
    DRUG METABOLISM REVIEWS, 2010, 42 : 305 - 306
  • [46] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Nies, Anne T.
    Niemi, Mikko
    Burk, Oliver
    Winter, Stefan
    Zanger, Ulrich M.
    Stieger, Bruno
    Schwab, Matthias
    Schaeffeler, Elke
    GENOME MEDICINE, 2013, 5
  • [47] Functional consequences of genetic variations in the human organic anion transporting polypeptide 1B3 (OATP1B3) in the Korean population
    Chae, Yoon-Jee
    Lee, Kyeong-Ryoon
    Noh, Chi-Kyung
    Chong, Saeho
    Kim, Dae-Duk
    Shim, Chang-Koo
    Chung, Suk-Jae
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (03) : 1302 - 1313
  • [48] INFLUENCE OF OATP1B1, OATP1B3 AND ABCC2 ON THE HEPATIC UPTAKE OF PRIMOVIST® IN HEALTHY VOLUNTEERS.
    Kuehn, J.
    Nassif, A.
    Oswald, S.
    Modess, C.
    Weitschies, W.
    Hosten, N.
    Siegmund, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S9 - S9
  • [49] Construction of HEK293 cells stably expressing wild-type organic anion transporting polypeptide 1B1 (OATP1B1☆1a) and variant OATP1B1☆1b and OATP1B1☆15
    Chen, M.
    Qu, B. X.
    Chen, X. L.
    Hu, H. H.
    Jiang, H. D.
    Yu, L. S.
    Zhou, Q.
    Zeng, S.
    PHARMAZIE, 2016, 71 (06): : 337 - 339
  • [50] Selectivity and Potency of Microcystin Congeners against OATP1B1 and OATP1B3 Expressing Cancer Cells
    Niedermeyer, Timo H. J.
    Daily, Abigail
    Swiatecka-Hagenbruch, Monika
    Moscow, Jeffrey A.
    PLOS ONE, 2014, 9 (03):
12345